To this end, we employ complementary in vitro and ex vivo approaches, including SMN-deficient human induced astrocytes (hiAstrocytes), murine astrocyte cultures, spinal cord slice preparations, and the Taiwanese mild SMA mouse model, which recapitulates the late-onset phenotype [16]. Here, SMN2 is linked to proximal spinal muscular atrophy.